China Literature Ltd
SWB:C2X
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China Literature Ltd
SWB:C2X
|
CN |
|
T
|
Tonnellerie Francois Freres SA
OTC:FRFTF
|
FR |
|
X
|
Xenon Pharmaceuticals Inc
F:XP0
|
CA |
|
C
|
Corbion NV
XMUN:CSUA
|
NL |
|
Webstep ASA
OSE:WSTEP
|
NO |
|
Next PLC
LSE:NXT
|
UK |
Intrinsic Value
Is C2X undervalued or overvalued?
See the intrinsic value estimate for 
China Literature Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
C2X looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with C2X’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What China Literature Does
China Literature Ltd is a Chinese digital reading and content company built around online fiction and other web-based stories. It runs a large library of licensed and original novels, lets readers access paid chapters and subscription content, and also connects writers with an audience through its writing and publishing platforms.
- Headquarters
- China CN
- Employees
- 1 700
- IPO date
- Nov 8, 2017
Earnings Waterfall
China Literature Ltd
The intrinsic value for China Literature Ltd (C2X) under the Base Case is hidden EUR.
Compared with the current market price of 2.2 EUR, the stock appears hidden.